Jinarc 15 mg

Jinarc 15 mg is a medicine authorised by Swissmedic under authorisation number 65676. The authorisation holder is Otsuka Pharmaceutical (Switzerland) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 April 2016 and the authorisation is valid without a time limit. ATC code C03XA01 places the medicine in the group Diuretics.

  • Dispensing category A
  • Authorisation number 65676
  • ATC C03XA01
  • Synthetic medicines
Authorisation data
Authorisation number65676
NameJinarc 15 mg
Full nameJinarc 15 mg, Tabletten
Authorisation holderOtsuka Pharmaceutical (Switzerland) GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeC03XA01
First authorisation21 April 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Jinarc 15 mg, TablettenA21 April 2016
2Jinarc 30 mg, TablettenA21 April 2016
3Jinarc 45 mg + 15 mg, TablettenA21 April 2016
4Jinarc 60 mg + 30 mg, TablettenA21 April 2016
5Jinarc 90 mg + 30 mg, TablettenA21 April 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
228Tablette(n)C03XA0105.02.0.A
428Tablette(n)C03XA0105.02.0.A
628 + 28Tablette(n)C03XA0105.02.0.A
928 + 28Tablette(n)C03XA0105.02.0.A
1228 + 28Tablette(n)C03XA0105.02.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Jinarc 15 mg authorised in Switzerland?

Yes. Jinarc 15 mg is authorised by Swissmedic under authorisation number 65676, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Jinarc 15 mg have?

Jinarc 15 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Jinarc 15 mg?

The authorisation holder is Otsuka Pharmaceutical (Switzerland) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com